DK1225890T3 - Rivastigmin til behandling af öjensygdomme - Google Patents

Rivastigmin til behandling af öjensygdomme

Info

Publication number
DK1225890T3
DK1225890T3 DK00992430T DK00992430T DK1225890T3 DK 1225890 T3 DK1225890 T3 DK 1225890T3 DK 00992430 T DK00992430 T DK 00992430T DK 00992430 T DK00992430 T DK 00992430T DK 1225890 T3 DK1225890 T3 DK 1225890T3
Authority
DK
Denmark
Prior art keywords
rivastigmine
treatment
eye diseases
diseases
eye
Prior art date
Application number
DK00992430T
Other languages
English (en)
Inventor
David Goldblum
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1225890T3 publication Critical patent/DK1225890T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00992430T 1999-10-19 2000-10-17 Rivastigmin til behandling af öjensygdomme DK1225890T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99120678 1999-10-19
PCT/EP2000/010234 WO2001028553A1 (en) 1999-10-19 2000-10-17 Rivastigmine for the treatment of ocular disorders

Publications (1)

Publication Number Publication Date
DK1225890T3 true DK1225890T3 (da) 2005-04-04

Family

ID=8239225

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00992430T DK1225890T3 (da) 1999-10-19 2000-10-17 Rivastigmin til behandling af öjensygdomme

Country Status (13)

Country Link
US (2) US6534541B1 (da)
EP (1) EP1225890B1 (da)
JP (1) JP2003512324A (da)
AR (1) AR026062A1 (da)
AT (1) ATE285764T1 (da)
AU (1) AU766001B2 (da)
CA (1) CA2384690C (da)
DE (1) DE60017174T2 (da)
DK (1) DK1225890T3 (da)
ES (1) ES2234708T3 (da)
NZ (1) NZ518164A (da)
PT (1) PT1225890E (da)
WO (1) WO2001028553A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141762A0 (en) 1998-10-01 2002-03-10 Novartis Ag New oral formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
CN107417574B (zh) * 2017-03-21 2019-12-03 浙江省医学科学院 2,4-双取代苯乙酮化合物及其旋光异构体、药学上可接受的盐及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74497A (en) * 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
NL195004C (nl) 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
US4900748A (en) 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
WO1993005779A1 (en) 1991-09-26 1993-04-01 The United States Of America Represented By The Secretary Department Of Health And Human Services Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
DE69233093T2 (de) 1991-09-26 2003-12-18 Us Gov Health & Human Serv Substituierte phenserine und phenylcarbamate von (-)-eserolin, (-)-n1-noreserolin und (-)-n1-benzylnoresorolin als spezifische acetylcholinesterase-inhibitoren
AU1138097A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of prostaglandins and miotics for lowering intraocular pressure

Also Published As

Publication number Publication date
US20030119832A1 (en) 2003-06-26
AU2834901A (en) 2001-04-30
PT1225890E (pt) 2005-05-31
NZ518164A (en) 2003-10-31
US6835748B2 (en) 2004-12-28
US6534541B1 (en) 2003-03-18
AU766001B2 (en) 2003-10-09
ATE285764T1 (de) 2005-01-15
AR026062A1 (es) 2002-12-26
WO2001028553A1 (en) 2001-04-26
CA2384690A1 (en) 2001-04-26
ES2234708T3 (es) 2005-07-01
CA2384690C (en) 2010-08-17
DE60017174T2 (de) 2005-12-22
EP1225890A1 (en) 2002-07-31
EP1225890B1 (en) 2004-12-29
JP2003512324A (ja) 2003-04-02
DE60017174D1 (de) 2005-02-03

Similar Documents

Publication Publication Date Title
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
FI20000863A (fi) Uusi hoitomenetelmä
NO20022087L (no) Fremgangsmåte for behandling av diabetes
DK1143977T3 (da) 2-oxy-benzoxazinonderivater til behandling af obesitas
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1176964T3 (da) Brug af ET743 til behandling af cancer
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
PT1154777E (pt) Medicamento para o tratamento de hipertensao arterial
NO20005179D0 (no) Medikament behandling
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
DK1225890T3 (da) Rivastigmin til behandling af öjensygdomme
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DE60138371D1 (de) PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie Photoretinitis
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
FI4299U1 (fi) Saunasuodatin
IS6020A (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
DK1341766T3 (da) Imidazolonderivater til behandling af virussygdomme